why choose us

First received: June 17, 2024

Clinical Trial: A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Respiratory Syncytial Virus (RSV)

Study Type: INTERVENTIONAL


Official Title: A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE FORMULATED IN MULTIDOSE VIALS IN HEALT

Brief Summary: Respiratory Syncytial Virus (RSV) is a common type of virus (germ) that can cause severe illness, where medical help is needed.RSV can lead to airway diseases in all ages.Vaccines help your body make antibodies.These antibodies help fight against diseases.This is called an immune response.The purpose of this study is to learn about the safety, tolerability, and immunogenicity of a RSV vaccine called RSVpreF.RSVpreF comes either as:a single dose in a container (called a vial),or in a vial that holds multiple…

Read more